The global biosurgery market size is expected to reach 20.1 billion by 2026, registering a CAGR of 7.1% during the forecast period, according to a new report by Grand View research, Inc. Factors such as the availability of multifunctional products and increasing number of surgeries due to prevalence of lifestyle related disease, obesity, and sports related injuries are projected to drive the growth. Biosurgery products are used in surgical procedures for adhesion or wound sealing and healing damaged bones and tissues.
Biosurgery
products are used for the treatment of chronic wounds, such as burns, foot
ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing
incidence of blood clotting among patients prone to excessive blood loss is
expected to drive the market growth. Moreover, rising need for blood loss
management and various severe trauma injuries is expected to drive the growth
of biosurgery market over the forecast period.
High
prevalence of diabetes increases the risk of wounds and infections, creating
requirement for biosurgery products. According to the American College of
Physicians, the global annual incidence of diabetic foot ulcer was 6.3% in
2017. This factor is projected to drive the product demand in the forthcoming
years. Moreover, rising geriatric population prone to various chronic diseases
is expected to propel the market. According to the World Health Organization
(WHO), the global aging population is expected to reach 2 billion by 2050, from
900 million in 2015. Application of biosurgery in other surgical procedures,
such as orthopedic, neurological, and gynecology surgeries is expected to drive
the market.
For Full Research Report On Biosurgery Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/biosurgery-market
Biosurgery Market
Report Highlights
- North America held the
largest market share in 2018, owing to favorable reimbursement policies,
local presence of key market players, and supportive government initiatives
- Based on product, surgical
sealant held the largest market share in 2018 and is expected to expand at
a CAGR of 6.8% over the forecast period
- By application, general
surgery held the largest market share in 2018. Cardiovascular surgery is
expected to register the fastest CAGR over the forecast period
- Some prominent players
operating in the biosurgery market are Johnson & Johnson (Ethicon);
Medtronic Plc; Strykers; Baxter International Inc.; C.R. Bard; Sanofi;
Pfizer; B. Braun Melsungen AG; and Integra LifeSciences Corporation
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/biosurgery-market/request/rs1
Biosurgery Market
Segmentation
Grand View Research has segmented
the global biosurgery market report on the basis of product, application, and
region:
Biosurgery Product
Outlook (Revenue, USD Million, 2015 - 2026)
- Surgical Sealants
- Hemostatic Agents
- Adhesion Barriers
- Soft Tissue Attachments
- Bone Graft Attachments
- Others
Biosurgery Application
Outlook (Revenue, USD Million, 2015 - 2026)
- General Surgery
- Orthopedic Surgery
- Cardiovascular surgery
- Neurological Surgery
- Others
Biosurgery Regional
Outlook (Revenue, USD Million, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment